Financial comparisons Incyte Corporation

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 22/04/2026 am IST			5-day change	1st Jan Change
96.22 ^USD	-0.72%		-1.50%	-2.58%

22/04	Incyte Insider Sold Shares Worth $1,801,366, According to a Recent SEC Filing	MT
17/04	Goldman Sachs Adjusts Incyte Price Target to $100 From $98, Maintains Neutral Rating	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Revenues (Y-1)	Net Margin (Y-1)	EBIT Margin (Y-1)	ROE (Y-1)	ROA (Y-1)	Leverage (Y-1)
INCYTE CORPORATION	514.12Cr	25.03%	31.43%	31.7%	22.02%	-1.81x
REGENERON PHARMACEUTICALS, INC.	1.43TCr	31.41%	34.05%	16.13%	12.48%	-1.09x
UCB	908.89Cr	20.13%	25.95%	14.03%	6.99%	-0x
SAMSUNG BIOLOGICS CO.,LTD.	395Cr	31.29%	39.94%	17.59%	11.33%	-0.18x
CSL LIMITED	1.56TCr	19.3%	28.72%	16.36%	7.75%	1.74x
BIOGEN INC.	989.06Cr	13.07%	28.69%	7.39%	4.5%	0.68x
MODERNA, INC.	194.4Cr	-145.16%	-158.13%	-28.87%	-21.31%	2.03x
SWEDISH ORPHAN BIOVITRUM AB	306.36Cr	1.69%	28.34%	14.97%	0.67%	0.88x
BRIDGEBIO PHARMA, INC.	50Cr	-144.39%	-104.25%	-	-78.14%	-2.48x
ALTEOGEN INC.	15Cr	66.87%	49.52%	39.67%	25.58%	1.24x
BIOMARIN PHARMACEUTICAL INC.	322.13Cr	10.83%	12.71%	5.94%	4.79%	-1.97x
AXSOME THERAPEUTICS, INC.	64Cr	-28.69%	-26.12%	-252.11%	-29.11%	0.85x
KRYSTAL BIOTECH, INC.	39Cr	52.64%	41.45%	18.91%	-	-
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	26Cr	-21.9%	-25.8%	-3.3%	-	-
GRIFOLS, S.A.	883.43Cr	5.34%	18.49%	6.14%	2.42%	4.83x
GAN & LEE PHARMACEUTICALS.	42Cr	20.18%	20.74%	5.55%	5.17%	-1.12x
SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.	105.06Cr	21.46%	26.05%	4.9%	5.4%	-
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	357.16Cr	7.74%	8.68%	6.46%	4.03%	3.63x
Average	455.63Cr	-0.73%	4.47%	-4.62%	-0.97%	0.48x
Weighted average by Cap.	783.06Cr	7.34%	13.57%	6.6%	3.74%	0.12x